PITTSBURGH--(BUSINESS WIRE)--Swing Therapeutics announced that Stanza, its digital therapeutic for treatment of fibromyalgia symptoms, has received a positive coverage decision from Highmark Health.

The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.

Shares of Tonix Pharmaceuticals opened the session higher after the company said its newly approved fibromyalgia treatment is commercially available by prescription at pharmacies in the U.S. Shares ...

The long search for an effective fibromyalgia pain treatment has finally yielded results. In a double-blind, controlled trial of 745 patients who had the frustrating ailment for a median of eight ...

Tonix Pharmaceuticals is advancing TNX-102 SL for fibromyalgia, aiming for FDA approval by August 2025 and potential 2025 launch. Tonix Pharmaceuticals Holding Corp. announced that the FDA will not ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations ...

(Reuters Health) – Individualized acupuncture treatments were tied to greater pain relief for people with fibromyalgia, according to results from a small trial in Spain that compared the approach to ...

Pharmacotherapy should not be a first-line approach to sleep disturbances in fibromyalgia. Cognitive behavioral therapy for insomnia (CBT-I) may be the most effective treatment for improving sleep ...

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. ...